The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Open accessAbstract
Mutational inactivation and allelic loss of the von Hippel-Lindau (VHL) gene appear to be causal events for the majority of spontaneous clear-cell renal carcinomas. We now show that hypermethylation of a normally unmethylated CpG island in the 5' region provides another potentially important mechanism for inactivation of the VHL gene in a significant portion of these cancers. This hypermethylation was found in 5 of 26 (19%) tumors examined. Four of these had lost one copy of VHL while one retained two heavily methylated alleles. Four of the tumors with VHL hypermethylation had no detectable mutations, whereas one had a missense mutation in addition to hypermethylation of the single retained allele. As would be predicted for the consequence of methylation in this 5' CpG island, none of the 5 tumors expressed the VHL gene. In contrast, normal kidney and all tumors examined with inactivating VHL gene mutations but no CpG island methylation had expression. In a renal cell culture line, treatment with 5-aza-2'-deoxycytidine resulted in reexpression of the VHL gene. These findings suggest that aberrant methylation of CpG islands may participate in the tumor-suppressor gene inactivations which initiate or cause progression of common human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Self-citationRole for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840
High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines
Antequera, F., Boyes, J., & Bird, A. (1990) · Cell · doi:10.1016/0092-8674(90)90015-7 · Cited by 699
Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma
Zbar, B., Brauch, H., Talmadge, C., & Linehan, M. (1987) · Nature · doi:10.1038/327721a0 · Cited by 638
Self-citationSTOGER, R. (1993) · Cell · doi:10.1016/0092-8674(93)90160-r · Cited by 598
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Greger, V., Passarge, E., H�pping, W., Messmer, E., & Horsthemke, B. (1989) · Human Genetics · doi:10.1007/bf00286709 · Cited by 574
Epigenetic mechanisms underlying the imprinting of the mouse H19 gene.
Bartolomei, M. S., Webber, A. L., Brunkow, M. E., & Tilghman, S. M. (1993) · Genes & Development · doi:10.1101/gad.7.9.1663 · Cited by 492
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., & Zbar, B. (1994) · PubMed · Cited by 471
Self-citationAllele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Parental-origin-specific epigenetic modification of the mouse H19 gene
Ferguson-Smith, A. C., Sasaki, H., Cattanach, B. M., & Surani, M. A. (1993) · Nature · doi:10.1038/362751a0 · Cited by 420
X-chromosome inactivation and cell memory
Riggs, A. D., & Pfeifer, G. P. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90219-t · Cited by 327
Increased Cytosine DNA-Methyltransferase Activity During Colon Cancer Progression
Issa, J.-P. J., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamilton, S. R., & Baylin, S. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.15.1235 · Cited by 312
CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
Ohtani‐Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., & Sakai, T. (1993) · PubMed · Cited by 311
el-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R. W., Falco, J. P., Hamilton, S. R., & Baylin, S. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3470 · Cited by 310
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.
Jones, P. A., Wolkowicz, M. J., Rideout, W. M., Gonzales, F. A., Marziasz, C. M., Coetzee, G. A., & Tapscott, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6117 · Cited by 234
Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W. C., de Bustros, A., Vertino, P. M., & Nelkin, B. D. (1991) · PubMed · Cited by 206
The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia.
de Bustros, A., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B., & Baylin, S. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5693 · Cited by 195
DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.
Kautiainen, T. L., & Jones, P. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35981-1 · Cited by 183
Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer.
Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., & Baylin, S. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1929 · Cited by 163
Self-citationMolecular and cellular characterization of human renal cell carcinoma cell lines.
Anglard, P., Trahan, E. E., Liu, S., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., & Linehan, W. M. (1992) · PubMed · Cited by 107
Self-citationMakos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J. D., Isaacs, W. B., Linehan, W. M., & Baylin, S. B. (1993) · PubMed · Cited by 98
Self-citationAbnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia
Nelkin, B. D., Przepiorka, D., Burke, P., Thomas, E., & Baylin, S. (1991) · Blood · doi:10.1182/blood.v77.11.2431.2431 · Cited by 81
DNA hypermethylation is associated with 17p allelic loss in neural tumors.
Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G. M., & Baylin, S. B. (1993) · PubMed · Cited by 75
Hout, A., Berg, E. D. V., Vlies, P. D. V., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530302 · Cited by 53
Tumor Suppressor Gene Allelic Loss in Human Renal Cancers
Brooks, J. D., Bova, G. S., Marshall, F. F., & Isaacs, W. B. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35760-9 · Cited by 47
Cited by
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Self-citationNext-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Metadata
- Authors
- Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-10-11
- Volume
- 91
- Issue
- 21
- Pages
- 9700-9704
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2150162153
- Cited by
- 1,529
- References
- 29
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.